World J Gastroenterol. 2011 September 28; 17(36): 4149-4152.
Published online 2011 September 28. doi: 10.3748/wjg.v17.i36.4149.
CD133 and membrane microdomains: Old facets for future hypotheses
Christine A Fargeas, Jana Karbanová, József Jászai and Denis Corbeil.
Christine A Fargeas, Jana Karbanová, József Jászai, Denis Corbeil, Tissue Engineering Laboratories (BIOTEC), Technische Universität Dresden, D-01307 Dresden, Germany
Author contributions: Fargeas CA, Karbanová J, Jászai J and Corbeil D contributed equally to this letter to the editor.
Correspondence to: Denis Corbeil, PhD, Tissue Engineering Laboratories (BIOTEC), Technische Universität Dresden, Tatzberg 47-49, D-01307 Dresden, Germany. corbeil@biotec.tu-dresden.de
Telephone: +49-351-46340118 Fax: +49-351-46340244
Received April 20, 2011; Revised June 16, 2011; Accepted June 23, 2011;
Abstract
Understanding all facets of membrane microdomains in normal and cancerous cells within the digestive tract is highly important, not only from a clinical point of view, but also in terms of our basic knowledge of cellular transformation. By studying the normal and cancer stem cell-associated molecule CD133 (prominin-1), novel aspects of the organization and dynamics of polarized epithelial cells have been revealed during the last decade. Its association with particular membrane microdomains is highly relevant in these contexts and might also offer new avenues in diagnosis and/or targeting of cancer stem cells.
Keywords: AC133, Cancer, CD133, Membrane microdomains, Membrane vesicles, Prominin-1, Stem cell